onlinepharmacyy.com@proxy.dreamhost.com – FDA Warning Letter
The FDA issued a Warning Letter to onlinepharmacyy.com for offering products in violation of the Federal Food, Drug, and Cosmetic Act. The website sells drugs like "Xanax (Generic)," "Valium (Brand)," "Viagra (Brand)," "Prozac (Generic)," "Acomplia (Generic)," "Acomplia (Brand)," "Rimonabant," and "Herbal Xanax."
The violations include marketing unapproved new drugs, specifically "Acomplia (Generic)," "Acomplia (Brand)," "Rimonabant," and "Herbal Xanax," which are defined as "new drugs" under section 201(p) of the Act. Rimonabant (Acomplia) was previously rejected by the FDA due to safety concerns. "Herbal Xanax" is also considered a new drug due to its intended use and name. The sale of these without FDA-approved applications violates sections 301(d) and 505(a).
Additionally, several products, including "Xanax (Generic)," "Valium (Brand)," "Viagra (Brand)," and "Prozac (Generic)," are misbranded under section 503(b)(1) because they are sold without requiring a prescription, and some are controlled substances. The website also falsely claims FDA approval for its products, making them misbranded under section 502(a). "Herbal
- Product type
- Drugs
ID · c7f177ee-be0c-4a0c-9599-702a8b0b7bc6
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.